From GERD to Barrett's esophagus: Is the pattern in Asia mirroring that in the West?

Journal of Gastroenterology and Hepatology (Australia)

Volumn 26, Issue 5, 2011, Pages 816-824

  Ho, Khek Yu ^a  

^a Dept Medicine Endocrinol Diabet   (Singapore)

Author keywords

Barrett's esophagus; Esophageal neoplasms; Esophagus Barrett's mucosa; Gastroesophagus reflux disease (GERD)

Indexed keywords

ASIA; BARRETT ESOPHAGUS; DISEASE ASSOCIATION; ESOPHAGEAL ADENOCARCINOMA; GASTROESOPHAGEAL REFLUX; HUMAN; MORBIDITY; PREVALENCE; PRIORITY JOURNAL; REFLUX ESOPHAGITIS; REVIEW; RISK FACTOR;

EID: 79954476945     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2011.06669.x     Document Type: Review

References (104)

1. Locke GR 3d, Talley NJ, Fett SL, Zinsmeister AR, Melton LJ 3d. Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota. Gastroenterology 1997; 112: 1448-56.
2. El-Serag H, Hill C, Jones R. Systematic review: the epidemiology of gastro-oesophageal reflux disease in primary care, using the UK General Practice Research Database. Aliment. Pharmacol. Ther. 2009; 29: 470-80.
3. Sharma P, Wani S, Romero Y, Johnson D, Hamilton F. Racial and geographic issues in gastroesophageal reflux disease. Am. J. Gastroenterol. 2008; 103: 2669-80.
4. Fujimoto K, Iwakiri R, Okamoto K etal. Characteristics of gastroesophageal reflux disease in Japan: increased prevalence in elderly women. J. Gastroenterol. 2003; 38 (Suppl. 15): 3-6.
5. Lim LG, Ho KY. Gastroesophageal reflux disease at the turn of millennium. World J. Gastroenterol. 2003; 9: 2135-6.
6. Hongo M, Shoji T. Epidemiology of reflux disease and CLE in East Asia. J. Gastroenterol. 2003; 38 (Suppl. 15): 25-30.
7. Watanabe T, Urita Y, Sugimoto M, Miki K. Gastroesophageal reflux disease symptoms are more common in general practice in Japan. World J. Gastroenterol. 2007; 13: 4219-23.
8. Lieberman DA, Oehlke M, Helfand M. Risk factors for Barrett's esophagus in community-based practice. Am. J. Gastroenterol. 1997; 92: 1293-7.
9. Cossentino MJ, Wong RK. Barrett's esophagus and risk of esophageal adenocarcinoma. Semin. Gastrointest. Dis. 2003; 14: 128-35.
10. Wong A, Fitzgerald RC. Epidemiologic risk factors for Barrett's esophagus and associated adenocarcinoma. Clin. Gastroenterol. Hepatol. 2005; 3: 1-10.
11. Van der Veen AH, Dees J, Blankensteijn JD etal. Adenocarcinoma in Barrett's oesophagus: an overrated risk. Gut 1989; 30: 14-18.
12. Solaymani-Dodaran M, Logan RF, West J, Card T, Coupland C. Risk of oesophageal cancer in Barrett's oesophagus and gastro-oesophageal reflux. Gut 2004; 53: 1070-4.
13. Shaheen NJ, Crosby MA, Bozymski EM, Sandler RS. Is there publication bias in the reporting of cancer risk in Barrett's esophagus? Gastroenterology 2000; 119: 333-8.
14. Rastogi A, Puli S, El-Serag HB, Bansal A, Wani S, Sharma P. Incidence of esophageal adenocarcinoma in patients with Barrett's esophagus and high-grade dysplasia: a meta-analysis. Gastrointest. Endosc. 2008; 67: 394-8.
15. Thomas T, Abrams KR, De Caestecker JS, Robinson RJ. Meta analysis: cancer risk in Barrett's oesophagus. Aliment. Pharmacol. Ther. 2007; 26: 1465-77.
16. Yousef F, Cardwell C, Cantwell MM, Galway K, Johnston BT, Murray L. The incidence of esophageal cancer and high-grade dysplasia in Barrett's esophagus: a systematic review and meta-analysis. Am. J. Epidemiol. 2008; 168: 237-49.
17. Dulai GS, Guha S, Kahn KL, Gornbein J, Weinstein WM. Preoperative prevalence of Barrett's esophagus in esophageal adenocarcinoma: a systematic review. Gastroenterology 2002; 122: 26-33.
18. Shaheen NJ, Richter JE. Barrett'soesophagus. Lancet 2009; 7: 850-61.
19. Spechler SJ, Fitzgerald RC, Prasad GA, Wang KK. History, molecular mechanisms, and endoscopic treatment of Barrett's esophagus. Gastroenterology 2010; 138: 854-69.
20. Jankowski J, Harrison RF, Perry I, Balkwill F, Tselepis C. Seminar: Barrett's metaplasia. Lancet 2000; 356: 2079-85.
21. Drewitz DJ, Sampliner RE, Garewal HS. The incidence of adenocarcinoma in Barrett's esophagus: a prospective study of 170 patients followed 4.8 years. Am. J. Gastroenterol. 1997; 92: 212-15.
22. O'Connor J, Falk G, Richter J. The incidence of adenocarcinoma and dysplasia in Barrett's esophagus: report on the Cleveland Clinic Barrett's esophagus Registry. Am. J. Gastroenterol. 1999; 94: 2037-42.
23. Corley DA, Levin TR, Habel LA, Weiss NS, Buffler PA. Surveillance and survival in Barrett's adenocarcinomas: a population-based study. Gastroenterology 2002; 122: 633-40.
24. Dent J, El-Serag HB, Wallander MA, Johansson S. Epidemiology of gastroesophageal reflux disease: a systematic review. Gut 2005; 54: 710-17.
25. Ho KY, Kang JY, Seow A. Prevalence of gastrointestinal symptoms in a multiracial Asian population, with particular reference to reflux-type symptoms. Am. J. Gastroenterol. 1998; 93: 1816-22.
26. Rosaida MS, Goh KL. Gastrooesophageal reflux disease, reflux oesophagitis and non-erosive reflux disease in a multiracial Asian population: a prospective, endoscopy based study. Eur. J. Gastroenterol. Hepatol. 2004; 16: 495- 501.
27. Rajendra S, Kutty K, Karim N. Ethnic differences in the prevalence of endoscopic esophagitis and Barrett's esophagus: the long and short of it all. Dig. Dis. Sci. 2004; 49: 237-42.
28. Rajendra S, Alahuddin S. Racial differences in the prevalence of heartburn. Aliment. Pharmacol. Ther. 2004; 19: 375-6.
29. El-Serag HB. Time trends of gastroesophageal reflux disease: a systematic review. Clin. Gastroenterol. Hepatol. 2007; 5: 17-26.
30. Fujiwara Y, Higuchi K, Watanabe Y etal. Prevalence of gastroesophageal reflux disease and gastroesophageal reflux disease symptoms in Japan. J. Gastroenterol. Hepatol. 2005; 20: 26-9.
31. Cho YS, Choi MG, Jeong JJ etal. Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Asan-si, Korea. Am. J. Gastroenterol. 2005; 100: 747-53.
32. Cho SC, Lee OY, Ha NR etal. The change in the prevalence of typical gastroesophageal reflux symptoms during the past 5 years in Korea: a population-based study. Korean J. Neurogastroenterol. Motil. 2008; 14: 96-102.
33. Kang MS, Park DI, Oh SY etal. Abdominal obesity is an independent risk factor for erosive esophagitis in a Korean population. J. Gastroenterol. Hepatol. 2007; 22: 1656-61.
34. He J, Ma X, Zhao Y etal. A population-based survey of the epidemiology of symptom-defined gastroesophageal reflux disease: the Systematic Investigation of Gastrointestinal Diseases in China. BMC Gastroenterol. 2010; 10: 94. Published online 2010 August 15. doi: 10.1186/1471-230X-10-94.
35. Chen M, Xiong L, Chen H, Xu A, He L, Hu P. Prevalence, risk factors and impact of gastroesophageal reflux disease symptoms: a population-based study in South China. Scand. J. Gastroenterol. 2005; 40: 759-67.
36. Wong WM, Lam SK, Hui WM etal. Long-term prospective follow-up of endoscopic oesophagitis in southern Chinese-prevalence and spectrum of the disease. Aliment. Pharmacol. Ther. 2002; 16: 2037-42.
37. Lu CL, Lang HC, Chang FY etal. Social and medical impact, sleep quality and the pharmaceutical costs of heartburn in Taiwan. Aliment. Pharmacol. Ther. 2005; 22: 739-47.
38. Bor S, Mandiracioglu A, Kitapcioglu G, Caymaz-Bor C, Gilbert RJ. Gastroesophageal reflux disease in a low-income region in Turkey. Am. J. Gastroenterol. 2005; 100: 759-65.
39. Mohammad JE, Iradj M, Fatemeh M, Ameneh M. Epidemiology of gastroesophageal reflux disease in Tehran, Iran. J. Gastroenterol. Hepatol. 2007; 22: 1419-22.
40. Ho KY, Chan YH, Kang JY. Increasing trend of reflux esophagitis and decreasing trend of Helicobacter pylori infection in patients from a multiethnic Asian country. Am. J. Gastroenterol. 2005; 100: 1923-8.
41. Furukawa N, Iwakiri R, Koyama T etal. Proportion of reflux esophagitis in 6010 Japanese adults-prospective evaluation by endoscopy. J. Gastroenterol. 1999; 34: 441-4.
42. Inamori M, Togawa J, Nagase H etal. Clinical characteristics of Japanese reflux esophagitis patients as determined by Los Angeles classification. J. Gastroenterol. Hepatol. 2003; 18: 172-6.
43. Mishima I, Adachi K, Arima N etal. Prevalence of endoscopically negative and positive gastroesophageal reflux disease in the Japanese. Scand. J. Gastroenterol. 2005; 40: 1005-9.
44. Lien HC, Chang CS, Yeh HZ etal. Increasing prevalence of erosive esophagitis among Taiwanese aged 40 years and above: a comparison between two time periods. J. Clin. Gastroenterol. 2009; 43: 926-32.
45. Tseng PH, Lee YC, Chiu HM etal. Prevalence and clinical characteristics of Barrett's esophagus in a Chinese general population. J. Clin. Gastroenterol. 2008; 42: 1074-9.
46. Wang FW, Tu MS, Chuang HY, Yu HC, Cheng LC, Hsu PI. Erosive esophagitis in asymptomatic subjects: risk factors. Dig. Dis. Sci. 2010; 55: 1320-4.
47. Hung CS, Lee CL, Yang JN etal. Clinical application of Carlsson's questionnaire to predict erosive GERD among healthy Chinese. J. Gastroenterol. Hepatol. 2005; 20: 1900-5.
48. Yeh C, Hsu CT, Ho AS, Sampliner RE, Fass R. Erosive esophagitis and Barrett's Esophagus in Taiwan: a higher frequency than expected. Dig. Dis. Sci. 1997; 42: 702-6.
49. Sollano JD, Wong SN, Andal-Gamutan T etal. Erosive esophagitis in the Philippines: a comparison between two time periods. J. Gastroenterol. Hepatol. 2007; 22: 1650-5.
50. Nam SY, Choi IJ, Ryu KH, Park BJ, Kim HB, Nam BH. Abdominal visceral adipose tissue volume is associated with increased risk of erosive esophagitis in men and women. Gastroenterology 2010; 139: 1902-11.
51. Kim JI, Kim SG, Kim N etal. Korean College of Helicobacter and Upper Gastrointestinal Research. Changing prevalence of upper gastrointestinal disease in 28893 Koreans from 1995 to 2005. Eur. J. Gastroenterol. Hepatol. 2009; 21: 787-93.
52. Song HJ, Shim KN, Yoon SJ etal. The prevalence and clinical characteristics of reflux esophagitis in koreans and its possible relation to metabolic syndrome. J Korean Med Sci. 2009; 24: 197-202.
53. Lee SJ, Song CW, Jeen YT etal. Prevalence of endoscopic reflux esophagitis among Koreans. J. Gastroenterol. Hepatol. 2001; 16: 373-6.
54. Song HJ, Choi KD, Jung HY etal. Endoscopic reflux esophagitis in patients with upper abdominal pain-predominant dyspepsia. J. Gastroenterol. Hepatol. 2007; 22: 2217-21.
55. Du J, Liu J, Zhang H, Yu CH, Li YM. Risk factors for gastroesophageal reflux disease, reflux esophagitis and non-erosive reflux disease among Chinese patients undergoing upper gastrointestinal endoscopic examination. World J. Gastroenterol. 2007; 13: 6009-15.
56. Pan G, Xu G, Ke M etal. Epidemiological study of symptomatic gastroesophageal reflux disease in China: Beijing and Shanghai. Chin. J. Dig. Dis. 2000; 1: 2-8.
57. Yilmaz N, Tuncer K, Tuncyurek M, Ozutemiz O, Bor S. The prevalence of Barrett's esophagus and erosive esophagitis in a tertiary referral center in Turkey. Turk. J. Gastroenterol. 2006; 17: 79-83.
58. Contractor QQ, ul Haque I, Saka H, Contractor TQ. Corpus gastritis and erosive esophagitis: a report from the Middle East. Indian J. Gastroenterol. 2006; 25: 295-7.
59. Nasseri-Moghaddam S, Malekzadeh R, Sotoudeh M etal. Lower esophagus in dyspeptic Iranian patients: a prospective study. J. Gastroenterol. Hepatol. 2003; 18: 315-21.
60. Endo M, Kobayashi S, Suzuki H, Takemoto T, Nakayama K. Diagnosis of early esophageal cancer. Endoscopy 1971; 2: 61-6.
61. Lim SL, Goh WT, Lee JM, Ng TP, Ho KY. Changing prevalence of gastroesophageal reflux with changing time: longitudinal study in an Asian population. J. Gastroenterol. Hepatol. 2005; 20: 995-1001.
62. Brown LM, Devesa SS, Chow WH. Incidence of adenocarcinoma of the esophagus among white americans by sex, stage, and age. J. Natl. Cancer Inst. 2008; 100: 1184-7.
63. Devesa SS, Blot WJ, Fraumeni JF Jr. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer 1998; 83: 2049-53.
64. Trivers KF, Sabatino SA, Stewart SL. Trends in esophageal cancer incidence by histology, United States, 1998-2003. Int. J. Cancer 2008; 123: 1422-8.
65. Pohl H, Sirovich B, Welch HG. Esophageal adenocarcinoma incidence: are we reaching the peak? Cancer Epidemiol. Biomarkers Prev. 2010; 19: 1468-70.
66. Amano Y, Kushiyama Y, Yuki T etal. Prevalence of and risk factors for Barrett's esophagus with intestinal predominant mucin phenotype. Scand. J. Gastroenterol. 2006; 41: 873-9.
67. Punia RS, Arya S, Mohan H, Duseja A, Bal A. Spectrum of clinico-pathological changes in Barrett oesophagus. J. Assoc. Physicians India. 2006; 54: 187-9.
68. Dhawan PS, Alvares JF, Vora IM etal. Prevalence of short segments of specialized columnar epithelium in distal esophagus: association with gastroesophageal reflux. Indian J. Gastroenterol. 2001; 20: 144-7.
69. Chang CY, Lee YC, Lee CT etal. The application of Prague C and M criteria in the diagnosis of Barrett's esophagus in an ethnic Chinese population. Am. J. Gastroenterol. 2009; 104: 13-20.
70. Kim JH, Rhee PL, Lee JH, etal. Prevalence and risk factors of Barrett's esophagus in Korea. J. Gastroenterol. Hepatol. 2007; 22: 908-12.
71. Xiong LS, Cui Y, Wang JP etal. Prevalence and risk factors of Barrett's esophagus in patients undergoing endoscopy for upper gastrointestinal symptoms. J. Dig. Dis. 2010; 11: 83-7.
72. Okita K, Amano Y, Takahashi Y etal. Barrett's esophagus in Japanese patients: its prevalence, form, and elongation. J. Gastroenterol. 2008; 43: 928-34.
73. Takubo K, Vieth M, Aida J etal. Differences in the definitions used for esophageal and gastric diseases in different countries: endoscopic definition of the esophagogastric junction, the precursor of Barrett's adenocarcinoma, the definition of Barrett's esophagus, and histologic criteria for mucosal adenocarcinoma or high-grade dysplasia. Digestion 2009; 80: 248-57.
74. Lee YC, Cook MB, Bhatia S etal. Interobserver reliability in the endoscopic diagnosis and grading of Barrett's esophagus: an Asian multinational study. Endoscopy 2010; 42: 699-704.
75. Fujiwara Y, Higuchi K, Shiba M etal. Association between gastroesophageal flap valve, reflux esophagitis, Barrett's epithelium, and atrophic gastritis assessed by endoscopy in Japanese patients. J. Gastroenterol. 2003; 38: 533-9.
76. Akiyama T, Inamori M, Akimoto K etal. Risk factors for the progression of endoscopic Barrett's epithelium in Japan: a multivariate analysis based on the Prague C & M Criteria. Dig. Dis. Sci. 2009; 54: 1702-7.
77. Azuma N, Endo T, Arimura Y etal. Prevalence of Barrett's esophagus and expression of mucin antigens detected by a panel of monoclonal antibodies in Barrett's esophagus and esophageal adenocarcinoma in Japan. J. Gastroenterol. 2000; 35: 583-92.
78. Zhang J, Chen XL, Wang KM, Guo XD, Zuo AL, Gong J. Barrett's esophagus and its correlation with gastroesophageal reflux in Chinese. World J. Gastroenterol. 2004; 10: 1065-8.
79. Kuo CJ, Lin CH, Liu NJ, Wu RC, Tang JH, Cheng CL. Frequency and risk factors for Barrett's esophagus in Taiwanese patients: a prospective study in a tertiary referral center. Dig. Dis. Sci. 2010; 55: 1337-43.
80. Peng S, Xiong LS, Xiao YL etal. Prompt upper endoscopy is an appropriate initial management in uninvestigated chinese patients with typical reflux symptoms. Am. J. Gastroenterol. 2010; 105: 1947-52.
81. Choi DW, Oh SN, Baek SJ etal. Endoscopically observed lower esophageal capillary patterns. Korean J.Intern. Med. 2002; 17: 245-8.
82. Lee JI, Park H, Jung HY, Rhee PL, Song CW, Choi MG. Prevalence of Barrett's esophagus in an urban Korean population: a multicenter study. J. Gastroenterol. 2003; 38: 23-7.
83. Lee IS, Choi SC, Shim KN, Jee SR etal. Prevalence of Barrett's esophagus remains low in the Korean population: nationwide cross-sectional prospective multicenter study. Dig. Dis. Sci. 2010; 55: 1932-9.
84. Kim JY, Kim YS, Jung MK etal. Prevalence of Barrett's esophagus in Korea. J. Gastroenterol. Hepatol. 2005; 20: 633-6.
85. Park JJ, Kim JW, Kim HJ etal. The prevalence of and risk factors for Barrett's esophagus in a Korean population: a nationwide multicenter prospective study. J. Clin. Gastroenterol. 2009; 43: 907-14.
86. Bayrakci B, Kasap E, Kitapcioglu G, Bor S. Low prevalence of erosive esophagitis and Barrett esophagus in a tertiary referral center in Turkey. Turk. J. Gastroenterol. 2008; 19: 145-51.
87. Bafandeh Y, Esmaili H, Aharizad S. Endoscopic and histologic findings in Iranian patients with heartburn. Indian J. Gastroenterol. 2005; 24: 236-8.
88. Rezailashkajani M, Roshandel D, Shafaee S, Zali MR. High prevalence of reflux oesophagitis among upper endoscopies of Iranian patients. Eur. J. Gastroenterol. Hepatol. 2007; 19: 499-506.
89. Odemiş B, Ciçek B, Zengin NI etal. Barrett's esophagus and endoscopically assessed esophagogastric junction integrity in 1000 consecutive Turkish patients undergoing endoscopy: a prospective study. Dis. Esophagus 2009; 22: 649-55.
90. Hongo M. Review article: Barrett's esophagus and carcinoma in Japan. Aliment. Pharmacol. Ther. 2004; 20: 50-4.
91. Fernandes ML, Seow A, Chan YH, Ho KY. Opposing trends in incidence of esophageal squamous cell carcinoma and adenocarcinoma in a multi-ethnic Asian country. Am. J. Gastroenterol. 2006; 101: 1430-6.
92. Yee YK, Cheung TK, Chan AO, Yuen MF, Wong BC. Decreasing trend of esophageal adenocarcinoma in Hong Kong. Cancer Epidemiol. Biomarkers Prev. 2007; 16: 2637-40.
93. Chung JW, Lee GH, Choi KS etal. Unchanging trend of esophagogastric junction adenocarcinoma in Korea: experience at a single institution based on Siewert's classification. Dis. Esophagus 2009; 22: 676-81.
94. Lu CL, Lang HC, Luo JC etal. Increasing trend of the incidence of esophageal squamous cell carcinoma, but not adenocarcinoma, in Taiwan. Cancer Causes Control 2010; 21: 269-74.
95. Wong BC, Kinoshita Y. Systematic review on epidemiology of gastroesophageal reflux disease in Asia. Clin. Gastroenterol. Hepatol. 2006; 4: 398-407.
96. JC W. Gastroesophageal reflux disease: an Asian perspective. J. Gastroenterol. Hepatol. 2008; 23: 1785-93.
97. Ma XQ, Cao Y, Wang R etal. Prevalence of, and factors associated with, gastroesophageal reflux disease: a population-based study in Shanghai, China. Dis. Esophagus 2009; 22: 317-22.
98. Lagergren J. Etiology and risk factors for oesophageal adenocarcinoma: possibilities for chemoprophylaxis? Best Pract. Res. Clin. Gastroenterol. 2006; 20: 803-12.
99. Cook MB, Kamangar F, Whiteman DC etal. Cigarette smoking and adenocarcinomas of the esophagus and esophagogastric junction: a pooled analysis from the international BEACON consortium. J. Natl. Cancer Inst. 2010; 102: 1344-53.
100. Cook MB, Greenwood DC, Hardie LJ, Wild CP, Forman D. A systematic review and meta-analysis of the risk of increasing adiposity on Barrett's esophagus. Am. J. Gastroenterol. 2008; 103: 292-300.
101. Corley DA, Kubo A, Levin TR etal. Abdominal obesity and body mass index as risk factors for Barrett's esophagus. Gastroenterology 2007; 133: 34-41.
102. Cook MB, Wild CP, Forman D. A systematic review and meta-analysis of the sex ratio for Barrett's esophagus, erosive reflux disease, and nonerosive reflux disease. Am. J. Epidemiol. 2005; 162: 1050-61.
103. Kubo A, Levin TR, Block G etal. Cigarette smoking and the risk of Barrett's esophagus. Cancer Causes Control 2009; 20: 303-11.
104. Kubo A, Block G, Quesenberry CP Jr, Buffler P, Corley DA. Effects of dietary fiber, fats, and meat intakes on the risk of Barrett's esophagus. Nutr. Cancer 2009; 61: 607-16.